Negroni 2017.
Study characteristics | ||
Methods | Retrospective cohort study | |
Participants | 26 people with PDH who were followed up after discharge (from 80 hospitalized participants) | |
Interventions | ITRA 200 mg OD (20 participants) dAmB twice/week (6 participants) Duration: until CD4 count > 150 cells/μL |
|
Outcomes | Not stated | |
Age | Mean 36 (range 18–60) years | |
Setting | ARG | |
Disease severity | Not stated | |
Notes |